Vinjar Fønnebø

TL;DR: Using the proposed strategy will generate evidence relevant to clinical practice, while acknowledging the absence of regulatory and financial gatekeepers for CAM, and emphasize the important but subtle differences between CAM and conventional medical practice.

TL;DR: Instead of an Evidence Hierarchy, a Circular Model is proposed, which would imply a multiplicity of methods, using different designs, counterbalancing their individual strengths and weaknesses to arrive at pragmatic but equally rigorous evidence which would provide significant assistance in clinical and health systems innovation.

TL;DR: Current evidence shows short-term beneficial effects of RYR preparations on lipid modification, but more rigorous trials are needed, and long-term effects and safety should be investigated if RYP preparations are to be recommended as one of the alternative treatments for primary hyperlipidemia.

TL;DR: Use of CAM is common in the Scandinavian countries, and there are national differences regarding therapy preferences, and many individuals use both CAM and conventional health services.

TL;DR: A consistent definition of CAM, a core set of CAMs with country-specific variations and a standardised reporting strategy to enhance the accuracy of data pooling would improve reporting quality.